Noradrenaline Kabi (Noradrenaline Tartrate)

Noradrenaline tartrate, the active ingredient in Noradrenaline Kabi, is a vasopressor presented as an injectable solution for intravenous use. It raises blood pressure and supports cardiac output in patients with severe hypotension, septic shock, or cardiac arrest. It is indicated for emergency management of circulatory failure and is manufactured according to EU GMP standards.

GNH USA supplies Noradrenaline Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The company provides temperature‑controlled logistics and complies with global regulatory requirements, enabling reliable delivery to intensive care units and emergency departments across continents.

Noradrenaline Kabi is a vasopressor used in critical care to restore vascular tone and improve perfusion.

- Hypotension: increases systemic vascular resistance to raise arterial pressure in patients with acute low blood pressure. - Septic shock: counteracts vasodilatory shock by constricting blood vessels and supporting organ perfusion. - Cardiac arrest: enhances coronary and cerebral blood flow during resuscitation efforts.

Noradrenaline Kabi may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Headache - Tachycardia - Peripheral ischemia - Nausea - Sweating

Serious or Rare Side Effects: - Myocardial ischemia - Severe hypertension - Tissue necrosis at infusion site - Anaphylactic reaction

When using Noradrenaline Kabi, careful monitoring and appropriate handling are essential.

- Blood pressure monitoring: continuous arterial pressure measurement is required during infusion. - Dose titration: adjust infusion rate to achieve target mean arterial pressure. - Cardiac function assessment: evaluate for underlying ischemia before initiating therapy. - Contraindication in uncontrolled hypertension: avoid rapid high‑dose bolus in patients with severe hypertension. - Peripheral vascular disease caution: monitor for limb ischemia and consider alternative agents. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Noradrenaline Kabi can interact with several drug classes; awareness of these interactions helps optimize therapy.

Major Interactions (Avoid): - MAO inhibitors: concurrent use may cause hypertensive crisis. - Tricyclic antidepressants: increased risk of severe hypertension. - Ergot alkaloids: additive vasoconstriction leading to ischemia.

Moderate Interactions (Monitor Closely): - Vasodilators (e.g., nitroglycerin): may reduce efficacy, requiring higher norepinephrine doses. - Beta‑blockers: can blunt β1‑mediated increase in cardiac output. - ACE inhibitors: may enhance hypotensive episodes during abrupt withdrawal.